Lunai Bioworks Inc.LNAI

$3.78-0.22 (-5.50%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$12M

Micro-cap

-76%

2025 — today

10-Year Price

-84%

2025 — today

52-Week Range

$1.48$18.24

Current $3.78· 14%

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Valuation in context

P/E ratio

-0.1

N/A

Not meaningful — company is unprofitable

P/B ratio

-1.2

N/A

Not meaningful — company is unprofitable

FCF Yield

-44.5%

Below average

Below the 10-year average

Free · No credit card needed

Get alerted when LNAI is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.